About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherapy and PARP Inhibitors in TNBC & Trastuzumab Biosimilars in HER2 BC
By
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
FEATURING
Jame Abraham
,
William Gradishar
By
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
FEATURING
Jame Abraham
,
William Gradishar
259 views
September 13, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:20
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…
Feat.
P. Tarantino
14:16
Dana-Farber Cancer Institute
Year in Review: Breast Cancer
Feat.
P. Tarantino
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
04:28
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …
Feat.
S. Tolaney
49:07
SABCS 2022 Conference Coverage
SABCS 2022 Expert Panel Discussion: Practice-Changing Updates
Feat.
J. O'Shaughnessy,
S. Tolaney,
S. Hurvitz,
H. Rugo
07:50
Oncology Data Advisor
ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…
Feat.
K. Kalinsky
22:34
Dana-Farber Cancer Institute
What's New in Breast Cancer?
Feat.
S. Tolaney
17:35
Insights from 2023 SABCS
SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…
Feat.
P. Tarantino
30:46
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"
Feat.
S. Tolaney,
H. Rugo
24:36
ESMO 2022 Conference Coverage
ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates
Feat.
H. Rugo,
J. O'Shaughnessy
12:21
Insights from 2023 SABCS
SABCS 2023 Insights: "How to Treat TNBC"
Feat.
P. Sharma
20:42
Total Health
2022 Updates in TNBC
Feat.
I. Schlam
13:23
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…
Feat.
S. Hurvitz
05:45
SABCS 2022 Conference Coverage
SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC:…
Feat.
S. Tolaney
03:37
Insights from 2023 SABCS
SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in …
Feat.
S. Tolaney,
H. Rugo
07:34
PrecisCa
Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…
Feat.
M. Pegram
11:19
Adam Brufsky
HER2+ mBC: The Role of TDM-1
07:49
UChicago Medicine
Antibody Drug Conjugates: Overview and Background of a Revolution in…
Feat.
H. Rugo
22:49
Oncology Data Advisor
Highlights of the 2023 SABCS: HER2CLIMB-02, MONARCH3, and INAVO120 T…
Feat.
J. Mouabbi
26:30
Insights from 2023 SABCS
SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…
Feat.
S. Tolaney,
H. Rugo
